Bio Pharma Dive
MARCH 16, 2021
Nearly $20 billion was invested in biotechs developing cell-, gene- and tissue-based treatments in 2020, according to a new report from industry group ARM.
World of DTC Marketing
MARCH 16, 2021
IN BRIEF: As a marketer, most of us, like a Jungian archetype, are true Communicators. Yet are those skills only reserved for big budgets, bold pitches, and grand innovations? Or do we, as individuals, have a special responsibility to the public at this moment in time? After all, we are already the translators of science for our clients. . A March 12th, Marist/NPR pole on vaccines is disturbing, but from what I have seen in everyday life, it is worse: · 25% of Black respondents and 28% of white
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 16, 2021
The commission, along with agencies in Europe, Canada and the U.K., plans to take a broader view of the potential anti-competitive effects to drug company acquisitions.
pharmaphorum
MARCH 16, 2021
European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. As it conducted its analysis of the vaccine in December, the European Medicines Agency’s systems were targeted by unknown hackers. Following this, more than 40 megabytes of classified information from the agency’s review were published on the dark web and several journalists, including th
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
MARCH 16, 2021
Global Blood says the two acquired programs could complement Oxbryta, its marketed sickle cell drug that gained approval in late 2019.
Scienmag
MARCH 16, 2021
Persistent work from scientists at The University of Toledo could aid in diagnosing and treating postural orthostatic tachycardia syndrome Credit: Daniel Miller / The University of Toledo The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding. There can be fatigue, pain, bleeding disorders and anxiety.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
MARCH 16, 2021
Pennsylvania-based Ocugen has struck a deal to sell 100 million doses of a COVID-19 vaccine India’s Bharat Biotech in the United States later this year.
Pharma Times
MARCH 16, 2021
Clinical Researcher of the Year – The Americas finalists reveal their positive experiences with the 2020 competition.
BioSpace
MARCH 16, 2021
France and Germany are two out of more than a dozen countries that suspended deployment of the AstraZeneca-Oxford University vaccine after reports of blood clots were reported.
Triage Cancer
MARCH 16, 2021
Extremely high medical bills are a huge problem in the United States, particularly for the cancer community. That’s why we are proud to announce our partnership with Upsolve , a free bankruptcy tool. Most people don’t realize that normally, filing for bankruptcy actually costs money. Bankruptcy is a powerful legal tool that wipes away debts from high medical bills, credit cards, job loss, and other financial shocks.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
MARCH 16, 2021
Algernon Pharmaceuticals has requested a pre-Investigational New Drug meeting with regulators in the hopes of launching a clinical trial in stroke patients for n,n-dimethyltryptamine, a naturally derived psychedelic compound.
BioPharma Reporter
MARCH 16, 2021
Biogen has estimated 10 million patients in the US are suitable for treatment with its Alzheimerâs disease candidate aducanumab, setting it up to generate blockbuster sales if it wins approval.
BioSpace
MARCH 16, 2021
Infectious disease-focused Vaccitech, which partnered with AstraZeneca and Oxford University on the development and manufacturing of that company’s COVID-19 vaccine, raised $168 million in a Series B financing round.
Scienmag
MARCH 16, 2021
Credit: Heng Luo An analysis published in the Journal of Computer Assisted Learning highlights 20 years of research on the use of virtual reality (VR) in K-12 schools and higher education. Investigators examined 149 articles from 2000-2019 from three major academic databases. They found that VR technology was implemented more extensively in higher education than […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
pharmaphorum
MARCH 16, 2021
The decision by around a dozen EU countries to suspend dosing with AstraZeneca’s COVID-19 vaccine is facing criticism, amid fears that it could undermine the response to the pandemic in Europe. . Germany, France, Italy and Spain are among the member states that have announced a suspension of dosing with AZD1222 in the last 24 hours as investigations into blood clots seen in 37 out of around 17 million people who have received the jab are investigated.
Scienmag
MARCH 16, 2021
Preclinical testing shows intravascular imaging approach can detect unstable coronary plaque Credit: Seemantini Nadkarni, Wellman Center for Photomedicine WASHINGTON — Researchers have developed a new intravascular imaging technique that could one day be used to detect coronary plaques that are likely to lead to a heart attack. Heart attacks are often triggered when an unstable […].
BioPharma Reporter
MARCH 16, 2021
US biotech, Moderna, reports today that the first participants have been dosed in its Phase 2/3 clinical trial investigating the efficacy of its COVID-19 vaccine in children ages 6 months to less than 12 years.
Scienmag
MARCH 16, 2021
Researchers from Osaka University showed that molecular iodine catalyzes a chemical transformation–important in antiviral and other pharmaceutical syntheses–that is otherwise difficult to achieve without use of toxic, rare metals Credit: Osaka University Osaka, Japan – Synthesizing pharmaceuticals for cancer, viral diseases, and other medical conditions is slow work.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
MARCH 16, 2021
Saamaâs range of Smart applications will be integrated with the Oracle Health Sciences Clinical One platform to help users accelerate drug development.
Scienmag
MARCH 16, 2021
Credit: FSU Coastal and Marine Laboratory/Scott Burgess Certain brightly colored coral species dotting the seafloor may appear indistinguishable to many divers and snorkelers, but Florida State University researchers have found that these genetically diverse marine invertebrates vary in their response to ocean warming, a finding that has implications for the long-term health of coral reefs. […].
pharmaphorum
MARCH 16, 2021
Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus. In a statement the company said the cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission. Detecting different variants of the virus can help assess the spread of circulating variants and monitor their potential impact on therapeutics, vaccines and public health interventions.
Scienmag
MARCH 16, 2021
A study simulating the effects of weightlessness also finds that impaired cognitive performance cannot be counteracted by short periods of artificial gravity Credit: DLR Living for nearly 2 months in simulated weightlessness has a modest but widespread negative effect on cognitive performance that may not be counteracted by short periods of artificial gravity, finds a […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
MARCH 16, 2021
Amathus Therapeutics, a biopharmaceutical company working on small molecule modulators across diverse genetically defined diseases, has entered into a strategic collaboration with Merck to develop novel small molecule treatment candidates for neurodegenerative diseases.
Scienmag
MARCH 16, 2021
Credit: Todd Wehner It’s a fact – humans love sugar. For those of us who also like to watch our calories, sugar substitutes can help. Some zero-calorie or low-calorie sweeteners have attracted bad reputations for containing unnatural ingredients. But there are also natural sweeteners derived from plants, like stevia. Stevia is hundreds of times sweeter […].
BioSpace
MARCH 16, 2021
BioSpace recently spoke with Sanjeev Luther, CEO and board member of Rafael Pharmaceuticals, a clinical-late stage metabolic therapeutics company.
Scienmag
MARCH 16, 2021
Federally funded study says drug delivery for certain common eye diseases could be improved Credit: University of Cincinnati Getting poked in the eye with a sharp object is a cringeworthy thought. However, many patients with posterior eye diseases — back of the eye diseases such as macular degeneration or diabetic retinopathy — undergo eye injections […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
MARCH 16, 2021
New biotech Antiverse has raised seed funding of £1.4 million ($2 million) to develop its artificial intelligence-based platform for discovering therapeutic antibodies. The Cardiff, Wales startup is combining machine learning and phage display techniques to model antibody-antigen binding and says it can cut the time it takes to develop a drug candidate.
Scienmag
MARCH 16, 2021
Credit: Graphic by Julie McMahon CHAMPAIGN, Ill. — Agricultural scientists who study climate change often focus on how increasing atmospheric carbon dioxide levels will affect crop yields. But rising temperatures are likely to complicate the picture, researchers report in a new review of the topic. Published in the Journal of Experimental Botany, the review explores […].
BioSpace
MARCH 16, 2021
The U.S. Attorney’s Office for Massachusetts charged Ishtiaq Ali Saaem, 37, with obstruction of justice for lying about his attempts to acquire 100 castor bean packets in order to develop the bioterror poison ricin. The acquisition was not recent, it took place on June 24, 2015.
Scienmag
MARCH 16, 2021
Credit: © MPI CPfS Superconductivity is a complete loss of electrical resistance. Superconductors are not merely very good metals: it is a fundamentally different electronic state. In normal metals, electrons move individually, and they collide with defects and vibrations in the lattice. In superconductors, electrons are bound together by an attractive force, which allows them […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
337 
Let's personalize your content